Open Accessibility Menu
Hide

Jon S. Du Bois, MD

  • JMC Physician Group
  • NPI Number: 1922080241
  • Position: Program Leader - Gastrointestinal, Neuroendocrine and Cutaneous Cancers
  • Languages Spoken: English
  • Gender: Male

About Jon

Dr. Du Bois is a board certified, fellowship trained, medical oncologist, hematologist, and part of a multidisciplinary team of cancer experts at The Anderson Family Cancer Institute. He works with other physician specialists to create a personalized treatment plan that’s best for you. Dr. Du Bois practices general oncology, seeing all types of cancer, with a subspecialty focus on gastrointestinal, neuroendocrine, and cutaneous cancers.

Prior to joining Jupiter Medical Center, he served as Medical Director of Massachusetts General Hospital Cancer Center at Emerson-Bethke, and Chief, Division of Hematology & Oncology at Emerson Hospital. Dr. Du Bois was also a Clinical Associate in Medicine for the Department of Medicine, Division of Hematology-Oncology at Massachusetts General Hospital, Harvard Medical School.

As your physician he may prescribe treatment to include chemotherapy, hormone therapy, targeted or molecular therapy, or immunotherapy. Supportive and palliative care can also be implemented to complement standard cancer therapies. Dr. Du Bois also provides second opinion services for cancer treatment.

Education
  • Medical School
  • Medical College of Pennsylvania Philadelphia, PA
  • Internship
  • Tufts Medical Center Boston, MA
  • Residency
  • Tufts Medical Center Boston, MA
  • Fellowship
  • Tufts Medical College Boston, MA
Medical Interests Areas of Interest:

Dr. Du Bois is a board certified, fellowship trained, medical oncologist, hematologist, and part of a multidisciplinary team of cancer experts at The Anderson Family Cancer Institute. He works with other physician specialists to create a personalized treatment plan that’s best for you. Dr. Du Bois practices general oncology, seeing all types of cancer, with a subspecialty focus on gastrointestinal, neuroendocrine, and cutaneous cancers.